MedPath

A multicenter prospective observational study to explore biomarkers of anti PD-1 antibody therapy for gastric cancer

Not Applicable
Conditions
Gastric cancer
Registration Number
JPRN-UMIN000044579
Lead Sponsor
Keio University Hospital Department of Internal Medicine, Division of Gastroenterology and Hepatology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients with active multiple cancers (concurrent multiple cancers/multiple cancers and heterogeneous multiple cancers/multiple cancers with disease-free interval of 3 years or less. (However, if the cancer is not a prognostic factor for the patient, it is not excluded.) (2) Patients with psychosis or psychiatric symptoms that interfere with daily life, making it difficult to participate in the study. 3) Other conditions deemed inappropriate by the physician in charge.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath